Published in Microvasc Res on November 10, 2011
In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cells. PLoS One (2014) 1.45
Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol (2012) 1.25
Adjusting the compass: new insights into the role of angiogenesis in Alzheimer's disease. Alzheimers Res Ther (2013) 0.78
Angiographic Structural Differentiation between Native Arteriogenesis and Therapeutic Synangiosis in Intracranial Arterial Steno-Occlusive Disease. AJNR Am J Neuroradiol (2016) 0.75
The biology of VEGF and its receptors. Nat Med (2003) 32.13
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol (1996) 15.20
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron (2008) 10.19
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol (1999) 9.32
Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med (2003) 8.54
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res (1995) 4.55
Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A (2003) 3.98
Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell (2004) 3.28
Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest (1991) 3.18
Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J (2002) 3.06
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol (2009) 2.85
Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med (2005) 2.71
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest (1990) 2.61
The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging (2000) 2.30
Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) Neurology (1996) 2.16
Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke (2002) 2.08
Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem (1999) 2.07
Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res (2003) 2.00
Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem (2001) 1.96
Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol (1992) 1.94
Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol (2011) 1.91
Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene (1997) 1.85
The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol (1977) 1.77
Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun (1998) 1.77
Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci (2002) 1.72
Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation (2011) 1.68
Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol (1994) 1.67
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging (2002) 1.56
Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging (2001) 1.56
HIF at a glance. J Cell Sci (2009) 1.55
Myocardial gene therapy. Nature (2002) 1.54
Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem (2009) 1.40
Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res (2008) 1.35
Modeling the neurovascular niche: implications for recovery from CNS injury. J Physiol Pharmacol (2009) 1.29
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (1994) 1.26
Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem (2000) 1.25
Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis. J Alzheimers Dis (2006) 1.24
Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun (2003) 1.24
Endothelial cells from diverse tissues exhibit differences in growth and morphology. Microvasc Res (1998) 1.22
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev Mol Med (2011) 1.22
Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med (1998) 1.20
Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res (1998) 1.16
Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. Clin Cancer Res (2000) 1.12
Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. Am J Pathol (2002) 1.11
High altitude cerebral edema and acute mountain sickness. A pathophysiology update. Adv Exp Med Biol (1999) 1.11
Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol Cell Physiol (2009) 1.10
Brain microvascular changes in Alzheimer's disease and other dementias. Ann N Y Acad Sci (1997) 1.09
Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol (2000) 1.08
Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells. J Exp Med (2000) 1.07
Hypoxia and neurodegeneration. Ann N Y Acad Sci (2009) 1.07
Angiogenic signaling in Alzheimer's disease. Neuroreport (2004) 1.05
The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. Am J Physiol Regul Integr Comp Physiol (2011) 1.04
Endothelin-1 and angiogenesis in cancer. Curr Vasc Pharmacol (2005) 1.03
Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J Neurochem (2007) 1.00
Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis (2006) 1.00
Mitochondrial quality control and neurological disease: an emerging connection. Expert Rev Mol Med (2010) 0.98
Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am J Pathol (2010) 0.98
Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer. Cell Tissue Res (2008) 0.96
Hypoxia and Alzheimer's disease. Essays Biochem (2007) 0.96
Oxygen sensing: a common crossroad in cancer and neurodegeneration. Curr Top Microbiol Immunol (2010) 0.95
Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol Res (2003) 0.95
Stress, exercise, and Alzheimer's disease: a neurovascular pathway. Med Hypotheses (2011) 0.91
Nitric oxide production is higher in rat cardiac microvessel endothelial cells than ventricular cardiomyocytes in baseline and hypoxic conditions: a comparative study. FASEB J (2005) 0.90
Aging and angiogenesis. Front Biosci (2003) 0.88
Heterogeneity in endothelial responsiveness to cytokines, molecular causes, and pharmacological consequences. Semin Thromb Hemost (2010) 0.88
Chronic cerebral hypoperfusion in a mouse model of Alzheimer's disease: an additional contributing factor of cognitive impairment. Neurosci Lett (2010) 0.87
Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci (2000) 0.86
Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition. Neuroscience (2008) 0.86
Hyperoxia enhances VEGF release from A549 cells via post-transcriptional processes. Free Radic Biol Med (2007) 0.86
Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc J Afr (2009) 0.85
Isolation and characterization of cerebral resistance vessel endothelium in culture. Tissue Cell (1993) 0.85
CRP-induced levels of oxidative stress are higher in brain than aortic endothelial cells. Cytokine (2010) 0.84
Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim. J Neural Transm (Vienna) (2010) 0.83
Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease. J Neurosci (2010) 0.83
Endothelin-1 is elevated in Alzheimer's disease brain microvessels and is neuroprotective. J Alzheimers Dis (2010) 0.83
Thrombospondins as anti-angiogenic therapeutic agents. Curr Pharm Des (2003) 0.82
Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis (2006) 0.82
Protection of thrombin receptor expression under hypoxia. J Biol Chem (2000) 0.80
Cerebral hypoxia and ischemia in the pathogenesis of dementia after stroke. Ann N Y Acad Sci (1997) 0.80
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J (2001) 12.88
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol (1999) 11.78
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 8.32
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis (2008) 6.97
A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86
Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg (2009) 6.73
Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med (1995) 6.56
Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev (1991) 6.30
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol (1996) 4.99
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol (2001) 4.50
The wheat and barley vernalization gene VRN3 is an orthologue of FT. Proc Natl Acad Sci U S A (2006) 4.38
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med (2000) 4.36
Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets. Nature (1983) 4.34
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
Rhizobium phaseoli symbiotic mutants with transposon Tn5 insertions. J Bacteriol (1984) 4.09
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat (1992) 3.63
Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care (2007) 3.54
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Immunization for Ebola virus infection. Nat Med (1998) 3.27
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia (2010) 2.83
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature (2005) 2.74
Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol (2001) 2.68
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Trop Med Int Health (2009) 2.35
Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile. Am J Epidemiol (1993) 2.31
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22
Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis (2000) 2.18
Efficacy of low-level laser therapy in the management of orthodontic pain: a systematic review and meta-analysis. Lasers Med Sci (2012) 2.15
Diagnostic and substance specificity of carbon-dioxide-induced panic. Am J Psychiatry (1993) 2.08
Social work at the emergency department. Eur J Emerg Med (1997) 2.04
Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology (1994) 2.01
Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy. J Am Acad Dermatol (1995) 2.01
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine (2000) 1.95
Traumatic anterior lens dislocation: a case report. J Emerg Med (1999) 1.91
Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem (1997) 1.86
Identification and analysis of Ebola virus messenger RNA. Virology (1987) 1.84
Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians. J Clin Microbiol (2003) 1.82
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol (1999) 1.82
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Differential carbon dioxide sensitivity in childhood anxiety disorders and nonill comparison group. Arch Gen Psychiatry (2000) 1.78
Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J Biol Chem (1997) 1.76
Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.76
Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology (1998) 1.73
The effect of intercourse on pregnancy rates during assisted human reproduction. Hum Reprod (2000) 1.71
Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun (1994) 1.69
Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2. Biochem J (1984) 1.69
Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. J Virol (1999) 1.68
Recombinant human monoclonal antibodies to Ebola virus. J Infect Dis (1999) 1.65
First-line Herceptin monotherapy in metastatic breast cancer. Oncology (2001) 1.60
High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature (1995) 1.57
Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis (1997) 1.56
P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol (2000) 1.55
Heterotaxia syndrome and autosomal dominant inheritance. Am J Med Genet (1995) 1.55
Unilateral "akathisia" in a patient with AIDS and a toxoplasmosis subthalamic abscess. Neurology (1989) 1.48
An inflamed elbow after an insect sting. Hosp Pract (1995) (1998) 1.47
Practical and economical method for using biotinylated DNA probes with bacterial colony blots to identify diarrhea-causing Escherichia coli. J Clin Microbiol (1990) 1.44
A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol (1997) 1.44
Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut (2005) 1.44
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. Virology (1997) 1.44
Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. Int J Infect Dis (2006) 1.43
Axonal pathology in myelin disorders. J Neurocytol (2000) 1.43
Mutation of the MXI1 gene in prostate cancer. Nat Genet (1995) 1.42
Loss of resolution in gel electrophoresis of RNA: a problem associated with the presence of formaldehyde gradients. Biotechniques (1993) 1.41
Elevated plasma glucagon in amyotrophic lateral sclerosis. Neurology (1992) 1.41
Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation. Bone Marrow Transplant (2004) 1.41
Reemergence of Ebola virus in Africa. Emerg Infect Dis (1996) 1.40
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. Diabetologia (2009) 1.39
Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: a case report. Neuroradiology (1995) 1.39
Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J Biol Chem (1990) 1.38
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies. Br J Cancer (2004) 1.38
Platelet kinetics in autosomal dominant macrothrombocytopenia. J Lab Clin Med (1998) 1.38
Haemothorax in the course of chickenpox. Thorax (1986) 1.38
Baseline entomological data for a pilot malaria control program in Equatorial Guinea. J Med Entomol (1993) 1.38
The alien hand syndrome. Clinical and postmortem findings. Arch Neurol (1989) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res (2001) 1.34
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) (2009) 1.34
Simulation of wheat growth and development based on organ-level photosynthesis and assimilate allocation. J Exp Bot (2010) 1.33
Depletion of a gamma delta T cell subset can increase host resistance to a bacterial infection. J Immunol (2000) 1.33
The nucleotide sequence of the L gene of Marburg virus, a filovirus: homologies with paramyxoviruses and rhabdoviruses. Virology (1992) 1.32
Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children. J Clin Microbiol (1992) 1.31
VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res (1998) 1.30
Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis (1999) 1.29
The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. J Gen Virol (1997) 1.29
Targeting xa13, a recessive gene for bacterial blight resistance in rice. Theor Appl Genet (2005) 1.28
Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain (2001) 1.28
Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. J Biol Chem (1998) 1.28
Reversibility of cerebral atrophy in anorexia nervosa and Cushing's syndrome. J Comput Assist Tomogr (1977) 1.27